COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,587 Articles (22,415 medRxiv, 8,172 bioRxiv)

Most recent first Previous |  Page 1759: Articles 17581-17590  | Next

Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2
Coyle, P. V., El Kahlout, R. A., Dargham, S. R., Chemaitelly, H., Kacem, M. A. B. H., Al-Mawlawi, N. H. A., Gillani, I., Younes, N., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Jeremijenko, A. M., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Tang, P. M., Bertollini, R., Al-Thani, M. H., Abu-Raddad, L. J.
10.1101/2021.02.04.21251126 — Posted: 2021-02-06
The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts
Maguire, D., McMillan, D.
10.1101/2021.02.04.21250932 — Posted: 2021-02-06
SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course StudyPotential Challenge for Vaccines and Therapies
Weber, S., Ramirez, C. C. M., Weiser, B., Burger, H., Doerfler, W.
10.1101/2021.02.04.21251111 — Posted: 2021-02-06
Prioritizing allocation of COVID-19 vaccines based on social contacts increases vaccination effectiveness
Chen, J., Hoops, S., Marathe, A., Mortveit, H., Lewis, B., Venkatramanan, S., Haddadan, A., Bhattacharya, P., Adiga, A., Vullikanti, A., Wilson, M., Ehrlich, G., Fenster, M., Eubank, S., Barrett, C., Marathe, M.
10.1101/2021.02.04.21251012 — Posted: 2021-02-06
Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning
Jamshidi, E., Asgary, A., Tavakoli, N., Zali, A., Dastan, F., Daaee, A., Badakhshan, M., Esmaily, H., Jamaldini, S. H., Safari, S., Bastanhagh, E., Maher, A., Babajani, A., Mehrazi, M., Sendani Kashi, M. A., Jamshidi, M., Sendani, M. H., Jamal Rahi, S., Mansouri, N.
10.1101/2021.02.04.21251143 — Posted: 2021-02-06
Was R<1 before the English lockdowns? On modelling mechanistic detail, causality and inference about Covid-19
Wood, S. N., Wit, E. C.
10.1101/2021.02.03.21251112 — Posted: 2021-02-06 Discussion: Onsite
Assessing knowledge, concerns, and risk perceptions among Italian medical students during the SARS-CoV-2 pandemic.
Greco, M., Maietti, E., Savoia, E., Trere, D., Reno, C., Rallo, F., Fantini, M. P., GORI, D.
10.1101/2021.02.04.21250922 — Posted: 2021-02-06
Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19
Thompson, M. A., Henderson, J. P., Shah, P. K., Rubinstein, S. M., Joyner, M. J., Choueiri, T. K., Flora, D. B., Griffiths, E. A., Gulati, A. P., Hwang, C., Koshkin, V. S., Papadopoulos, E. B., Robilotti, E. V., Su, C. T., Wulff-Burchfield, E. M., Xie, Z., Yu, P. P., Mishra, S., Senefeld, J. W., Shah, D. P., Warner, J. L., COVID-19 and Cancer Consortium
10.1101/2021.02.05.21250953 — Posted: 2021-02-05
Efficacy of Ivermectin in COVID-19 Patients with Mild to Moderate Disease
Bukhari, S. K. H. S., Asghar, A., Perveen, N., Hayat, A., Mangat, S. A., Butt, K. R., Abdullah, M., Fatima, T., Mustafa, A., Cheema, T.
10.1101/2021.02.02.21250840 — Posted: 2021-02-05
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors
Vickers, M., Sariol, A., Leon, J., Ehlers, A., Locher, A., DuBay, K., Collins, L., Voss, D., Odle, A., Holida, M., Merrill, A., Perlman, S., Knudson, M.
10.1101/2021.02.02.21250836 — Posted: 2021-02-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).